Login/Sign Up
Online payment accepted
Provide Delivery Location
Whats That
Therapeutic Class
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Gibtulio Met 12.5/500 Tablet is composed of two antidiabetic medicines, namely: Empagliflozin and Metformin. Empagliflozin works by increasing the amount of sugar that leaves your body in your pee. Metformin lowers your blood sugar levels by improving the way your body handles insulin. Altogether, they lower blood glucose more effectively.
Your doctor may advise Gibtulio Met 12.5/500 Tablet with or without other medications to control your blood sugar levels. However, it is advised to maintain a proper diet and exercise to control blood sugar levels while using Gibtulio Met 12.5/500 Tablet with or without other antidiabetic drugs.
It is not recommended to use Gibtulio Met 12.5/500 Tablet along with diuretics. Simultaneous use of Gibtulio Met 12.5/500 Tablet with diuretics can cause dehydration, and may these can increase your risk of dehydration and lower your blood pressure.
Diabetes is normally treated for the rest of one's life. Do not discontinue taking Gibtulio Met 12.5/500 Tablet pills without first consulting your doctor.
It is safe to take empagliflozin for a long time. There is no proof that this medication is harmful to your overall health.
Take the missed dose as soon as possible. However, if it is time for the next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose.
Alcohol
Caution
It is advised to avoid alcohol intake since it may worsen the side effects like lactic acidosis and increase the risk of developing low blood sugar levels.
Pregnancy
Caution
Empagliflozin in Gibtulio Met 12.5/500 Tablet is not generally recommended in pregnancy. It is not clear whether empagliflozin can harm an unborn baby. Your doctor may suggest other medications to control your blood sugar levels. Please consult your doctor before starting the Gibtulio Met 12.5/500 Tablet if you are pregnant or planning to conceive.
Breast Feeding
Caution
Gibtulio Met 12.5/500 Tablet may be unsafe to use during breastfeeding since it is excreted into breast milk. Please seek medical advice for further information.
Driving
Caution
You’re driving may be affected if your blood sugar levels are too high or too low. Do not drive or operate machinery if you also experience blurred vision, dizziness or drowsiness due to extremely low or high blood sugar.
Liver
Caution
Inform your doctor before receiving Gibtulio Met 12.5/500 Tablet if you have a liver impairment/disorder history. Your doctor will prescribe only if the benefits outweigh the risks.
Kidney
Caution
Inform your doctor before receiving Gibtulio Met 12.5/500 Tablet if you have a kidney impairment/disorder history. Your doctor will prescribe only if the benefits outweigh the risks.
Children
Unsafe
Gibtulio Met 12.5/500 Tablet is not recommended for people younger than 18 years of age.
Product Substitutes
About Gibtulio Met 12.5/500 Tablet
Gibtulio Met 12.5/500 Tablet is a combination drug that belongs to the antidiabetic class. It is primarily used to treat Type 2 diabetes. Type 2 diabetes is a common condition that causes the level of glucose (sugar) in the blood to become too high. It's a lifelong condition that can affect your everyday life. You may need to change your diet, take medicines and have regular check-ups to lead a normal life.
Gibtulio Met 12.5/500 Tablet is composed of two antidiabetic medicines: Empagliflozin and Metformin. Empagliflozin is a type of medicine known as a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It reduces blood sugar levels in people with diabetes. It does this by helping remove excess sugar from your body through your pee. Metformin belongs to the class of biguanides and manages blood sugar levels, particularly in obese patients. It lowers your blood sugar levels by improving how your body handles insulin. Altogether, they lower blood glucose more effectively.
Take this medication by mouth with or without food as directed by your doctor, usually once daily in the morning. The dosage is based on your medical condition and response to treatment. Use this medication regularly to get the most benefit from it. To help you remember, take it at the same time each day. Tell your doctor if your condition does not improve or worsens (if your blood sugar is too high or too low). In some cases, you may experience certain common side effects, such as frequent urination, mild skin rash or itchy skin, feeling sick (nausea), being sick (vomiting) or diarrhoea, stomach ache, and loss of appetite. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Before taking this medication, tell your doctor or pharmacist if you are allergic to Empagliflozin and Metformin; or have other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Gibtulio Met 12.5/500 Tablet should not be stopped even if you feel better, without consulting your doctor as your sugar level keeps changing. If you stop taking Gibtulio Met 12.5/500 Tablet abruptly, it may increase your sugar levels which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy), and nerve damage (neuropathy). Gibtulio Met 12.5/500 Tablet should not be taken if you have type 1 diabetes mellitus or severe kidney or liver disease. During pregnancy/lactation, this medication should be used only when needed. Discuss the risks and benefits with your doctor.
Uses of Gibtulio Met 12.5/500 Tablet
Medicinal Benefits
Gibtulio Met 12.5/500 Tablet is composed of two antidiabetic medicines: Empagliflozin and Metformin. Empagliflozin is a type of medicine known as a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It reduces blood sugar levels in people with diabetes. It does this by helping remove excess sugar from your body through your pee. Metformin belongs to the class of biguanides and manages blood sugar levels, particularly in obese patients. It lowers your blood sugar levels by improving how your body handles insulin. Altogether, they lower blood glucose more effectively.
Directions for Use
Side Effects of Gibtulio Met 12.5/500 Tablet
Drug Warnings
Before taking this medication, tell your doctor or pharmacist if you are allergic to Empagliflozin and Metformin; or have other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Gibtulio Met 12.5/500 Tablet should not be stopped even if you feel better, without consulting your doctor as your sugar level keeps changing. If you stop taking Gibtulio Met 12.5/500 Tablet abruptly, it may increase your sugar levels which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy), and nerve damage (neuropathy). Gibtulio Met 12.5/500 Tablet should not be taken if you have type 1 diabetes mellitus or severe kidney or liver disease. It's generally not recommended to take empagliflozin during pregnancy/breastfeeding. Discuss the risks and benefits with your doctor. Gibtulio Met 12.5/500 Tablet is only for adults (from 18 years). It is not recommended for anyone aged 85 years or older.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
Login/Sign Up
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise
by AYUR
by Others
by Others
by Others
by Others
Have a query?
Buy best Diabetics products by
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Eris Life Sciences Ltd
Intas Pharmaceuticals Ltd
Lupin Ltd
Micro Labs Ltd
Mankind Pharma Pvt Ltd
Lloyd Healthcare Pvt Ltd
Alkem Laboratories Ltd
Abbott India Ltd
Glenmark Pharmaceuticals Ltd
Cipla Ltd
Macleods Pharmaceuticals Ltd
Wockhardt Ltd
Dr Reddy's Laboratories Ltd
Primus Remedies Pvt Ltd
USV Pvt Ltd
Aristo Pharmaceuticals Pvt Ltd
Emcure Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd
Ipca Laboratories Ltd
La Renon Healthcare Pvt Ltd
Ajanta Pharma Ltd
Medley Pharmaceuticals Ltd
East West Pharma India Pvt Ltd
Elbrit Life Sciences Pvt Ltd
Corona Remedies Pvt Ltd
Hbc Life Sciences Pvt Ltd
Sinsan Pharmaceuticals Pvt Ltd
Ranmarc Labs
Mitoch Pharma Pvt Ltd
Zydus Healthcare Ltd
Sanofi India Ltd
Akumentis Healthcare Ltd
Fusion Health Care Pvt Ltd
Unison Pharmaceuticals Pvt Ltd
Jubilant Lifesciences Ltd
Novo Nordisk India Pvt Ltd
Tas Med India Pvt Ltd
Blue Cross Laboratories Pvt Ltd
Msn Laboratories Pvt Ltd
Eswar Therapeutics Pvt Ltd
Indoco Remedies Ltd
Q Check Pharmaceuticals
Alteus Biogenics Pvt Ltd
Anthem Bio Pharma
Franco Indian Pharmaceuticals Pvt Ltd
Systopic Laboratories Pvt Ltd
Panacea Biotec Ltd
Zydus Cadila
Biocon Ltd
Edoc Life Sciences Pvt Ltd
Koye Pharmaceuticals Pvt Ltd
Arkas Pharma Pvt Ltd
Diacardus Pharmacy Pvt Ltd
Elinor Pharmaceuticals (P) Ltd
Remedy Life Sciences Pvt Ltd
Saan Labs
Talent India Pvt Ltd
Jarun Pharmaceuticals Pvt Ltd
Capital Pharma
Shrrishti Health Care Products Pvt Ltd
FDC Ltd
Leeford Healthcare Ltd
Nirvana India Pvt Ltd
Elder Pharmaceuticals Ltd
Eli Lilly and Company (India) Pvt Ltd
Glynis Pharmaceuticals Pvt Ltd
Zuventus Healthcare Ltd
Arrient Healthcare Pvt Ltd
Cadomed Pharmaceuticals India Pvt Ltd
Orris Pharmaceuticals
Akesiss Pharma Pvt Ltd
Bal Pharma Ltd
Biochem Pharmaceutical Industries Ltd
Knoll Healthcare Pvt Ltd
Lippon Pharma Pvt Ltd
Morepen Laboratories Ltd
Neucure Lifesciences Pvt Ltd
Opsis Care Lifesciences Pvt Ltd
Wallace Pharmaceuticals Pvt Ltd
Acmedix Pharma Llp
Converge Biotech Pvt Ltd
Erinyle Pharma
Indiabulls Pharmaceuticals Pvt Ltd
Ozone Pharmaceuticals Ltd
Retra Life Science Pvt Ltd
Alvio Pharmaceuticals Pvt Ltd
Geneaid Pharmaceuticals
Heal (India) Laboratories Pvt Ltd
Olcare Laboratories Pvt Ltd
Vasu Organics Pvt Ltd
Kotak Life Sciences
Lakshya Life Sciences Pvt Ltd
Proqol Health Care Pvt Ltd
Sanz Pharmaceuticals
Daylon healthcare pvt Ltd
Mcronus Lifescience Pvt Ltd
Natco Pharma Ltd
Orsim Pharma
Customers Also Bought
Recommended for a 30-day course: 3 Strips